1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine

C160H284F9N19O7 — CID 163803537

IUPAC1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine
SMILESCC(C)(C)N1CCCC(O)C1.CC(C)(C)N1CCCC(c2ccccc2)C1.CC(C)(C)N1CCOC(c2ccccc2)C1.CC(C)(C)N1CCOCC1.CC(C)(C)NCCCN1CCCCC1.CC(C)(C)NCCCN1CCOCC1.CC(C)(C)NCCCc1ccccn1.CC(C)(C)NCc1ccccn1.CC(C)(C)OCc1ccc(C(F)(F)F)cc1.CC(C)(C)OCc1ccc(C(F)(F)F)cn1.CC(C)(C)OCc1cccc(C(F)(F)F)c1.CN(C)C1CCCN(C(C)(C)C)C1.CN(C)C1CCN(C(C)(C)C)CC1.CN(C)CC1CCN(C(C)(C)C)CC1
InChIInChI=1S/C15H23N.C14H21NO.2C12H15F3O.C12H26N2.C12H20N2.C12H26N2.C11H14F3NO.C11H24N2O.2C11H24N2.C10H16N2.C9H19NO.C8H17NO/c1-15(2,3)16-11-7-10-14(12-16)13-8-5-4-6-9-13;1-14(2,3)15-9-10-16-13(11-15)12-7-5-4-6-8-12;1-11(2,3)16-8-9-4-6-10(7-5-9)12(13,14)15;1-11(2,3)16-8-9-5-4-6-10(7-9)12(13,14)15;1-12(2,3)14-8-6-11(7-9-14)10-13(4)5;1-12(2,3)14-10-6-8-11-7-4-5-9-13-11;1-12(2,3)13-8-7-11-14-9-5-4-6-10-14;1-10(2,3)16-7-9-5-4-8(6-15-9)11(12,13)14;1-11(2,3)12-5-4-6-13-7-9-14-10-8-13;1-11(2,3)13-8-6-10(7-9-13)12(4)5;1-11(2,3)13-8-6-7-10(9-13)12(4)5;1-10(2,3)12-8-9-6-4-5-7-11-9;1-9(2,3)10-6-4-5-8(11)7-10;1-8(2,3)9-4-6-10-7-5-9/h4-6,8-9,14H,7,10-12H2,1-3H3;4-8,13H,9-11H2,1-3H3;2*4-7H,8H2,1-3H3;11H,6-10H2,1-5H3;4-5,7,9,14H,6,8,10H2,1-3H3;13H,4-11H2,1-3H3;4-6H,7H2,1-3H3;12H,4-10H2,1-3H3;2*10H,6-9H2,1-5H3;4-7,12H,8H2,1-3H3;8,11H,4-7H2,1-3H3;4-7H2,1-3H3
InChIKeyNHAFWVKFYGVLDW-UHFFFAOYSA-N
MW2757.14 g/mol
LogP33.74
Rot. Bonds26

About 1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine

1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine (PubChem CID 163803537) has the molecular formula C160H284F9N19O7 and a molecular weight of 2757.14 g/mol. Its IUPAC name is 1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine.

Molecular Properties

Compound Name1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine
PubChem CID163803537
Molecular FormulaC160H284F9N19O7
Molecular Weight2757.14 g/mol
Exact Mass2755.23
IUPAC Name1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine
SMILESCC(C)(C)N1CCCC(O)C1.CC(C)(C)N1CCCC(c2ccccc2)C1.CC(C)(C)N1CCOC(c2ccccc2)C1.CC(C)(C)N1CCOCC1.CC(C)(C)NCCCN1CCCCC1.CC(C)(C)NCCCN1CCOCC1.CC(C)(C)NCCCc1ccccn1.CC(C)(C)NCc1ccccn1.CC(C)(C)OCc1ccc(C(F)(F)F)cc1.CC(C)(C)OCc1ccc(C(F)(F)F)cn1.CC(C)(C)OCc1cccc(C(F)(F)F)c1.CN(C)C1CCCN(C(C)(C)C)C1.CN(C)C1CCN(C(C)(C)C)CC1.CN(C)CC1CCN(C(C)(C)C)CC1
InChIInChI=1S/C15H23N.C14H21NO.2C12H15F3O.C12H26N2.C12H20N2.C12H26N2.C11H14F3NO.C11H24N2O.2C11H24N2.C10H16N2.C9H19NO.C8H17NO/c1-15(2,3)16-11-7-10-14(12-16)13-8-5-4-6-9-13;1-14(2,3)15-9-10-16-13(11-15)12-7-5-4-6-8-12;1-11(2,3)16-8-9-4-6-10(7-5-9)12(13,14)15;1-11(2,3)16-8-9-5-4-6-10(7-9)12(13,14)15;1-12(2,3)14-8-6-11(7-9-14)10-13(4)5;1-12(2,3)14-10-6-8-11-7-4-5-9-13-11;1-12(2,3)13-8-7-11-14-9-5-4-6-10-14;1-10(2,3)16-7-9-5-4-8(6-15-9)11(12,13)14;1-11(2,3)12-5-4-6-13-7-9-14-10-8-13;1-11(2,3)13-8-6-10(7-9-13)12(4)5;1-11(2,3)13-8-6-7-10(9-13)12(4)5;1-10(2,3)12-8-9-6-4-5-7-11-9;1-9(2,3)10-6-4-5-8(11)7-10;1-8(2,3)9-4-6-10-7-5-9/h4-6,8-9,14H,7,10-12H2,1-3H3;4-8,13H,9-11H2,1-3H3;2*4-7H,8H2,1-3H3;11H,6-10H2,1-5H3;4-5,7,9,14H,6,8,10H2,1-3H3;13H,4-11H2,1-3H3;4-6H,7H2,1-3H3;12H,4-10H2,1-3H3;2*10H,6-9H2,1-5H3;4-7,12H,8H2,1-3H3;8,11H,4-7H2,1-3H3;4-7H2,1-3H3
InChIKeyNHAFWVKFYGVLDW-UHFFFAOYSA-N
XLogP33.74
TPSA201.28 Ų
H-Bond Donors5
H-Bond Acceptors26
Rotatable Bonds26
Heavy Atoms195
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002757.14
LogP ≤ 533.74
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine?
The IUPAC name of 1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine (CID 163803537) is 1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine.
What is the SMILES notation for 1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine?
The canonical SMILES for 1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine is CC(C)(C)N1CCCC(O)C1.CC(C)(C)N1CCCC(c2ccccc2)C1.CC(C)(C)N1CCOC(c2ccccc2)C1.CC(C)(C)N1CCOCC1.CC(C)(C)NCCCN1CCCCC1.CC(C)(C)NCCCN1CCOCC1.CC(C)(C)NCCCc1ccccn1.CC(C)(C)NCc1ccccn1.CC(C)(C)OCc1ccc(C(F)(F)F)cc1.CC(C)(C)OCc1ccc(C(F)(F)F)cn1.CC(C)(C)OCc1cccc(C(F)(F)F)c1.CN(C)C1CCCN(C(C)(C)C)C1.CN(C)C1CCN(C(C)(C)C)CC1.CN(C)CC1CCN(C(C)(C)C)CC1.
What is the InChIKey of 1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine?
The InChIKey is NHAFWVKFYGVLDW-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H23N.C14H21NO.2C12H15F3O.C12H26N2.C12H20N2.C12H26N2.C11H14F3NO.C11H24N2O.2C11H24N2.C10H16N2.C9H19NO.C8H17NO/c1-15(2,3)16-11-7-10-14(12-16)13-8-5-4-6-9-13;1-14(2,3)15-9-10-16-13(11-15)12-7-5-4-6-8-12;1-11(2,3)16-8-9-4-6-10(7-5-9)12(13,14)15;1-11(2,3)16-8-9-5-4-6-10(7-9)12(13,14)15;1-12(2,3)14-8-6-11(7-9-14)10-13(4)5;1-12(2,3)14-10-6-8-11-7-4-5-9-13-11;1-12(2,3)13-8-7-11-14-9-5-4-6-10-14;1-10(2,3)16-7-9-5-4-8(6-15-9)11(12,13)14;1-11(2,3)12-5-4-6-13-7-9-14-10-8-13;1-11(2,3)13-8-6-10(7-9-13)12(4)5;1-11(2,3)13-8-6-7-10(9-13)12(4)5;1-10(2,3)12-8-9-6-4-5-7-11-9;1-9(2,3)10-6-4-5-8(11)7-10;1-8(2,3)9-4-6-10-7-5-9/h4-6,8-9,14H,7,10-12H2,1-3H3;4-8,13H,9-11H2,1-3H3;2*4-7H,8H2,1-3H3;11H,6-10H2,1-5H3;4-5,7,9,14H,6,8,10H2,1-3H3;13H,4-11H2,1-3H3;4-6H,7H2,1-3H3;12H,4-10H2,1-3H3;2*10H,6-9H2,1-5H3;4-7,12H,8H2,1-3H3;8,11H,4-7H2,1-3H3;4-7H2,1-3H3.
What are the key properties of 1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine?
1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine has a molecular weight of 2757.14 g/mol, XLogP of 33.74, 26 rotatable bonds, 5 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 1-tert-butyl-N,N-dimethylpiperidin-3-amine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;4-tert-butylmorpholine;4-tert-butyl-2-phenylmorpholine;1-tert-butyl-3-phenylpiperidine;1-tert-butylpiperidin-3-ol;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;2-methyl-N-(3-morpholin-4-ylpropyl)propan-2-amine;2-methyl-N-(3-piperidin-1-ylpropyl)propan-2-amine;1-[(2-methylpropan-2-yl)oxymethyl]-3-(trifluoromethyl)benzene;1-[(2-methylpropan-2-yl)oxymethyl]-4-(trifluoromethyl)benzene;2-[(2-methylpropan-2-yl)oxymethyl]-5-(trifluoromethyl)pyridine;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(3-pyridin-2-ylpropyl)propan-2-amine is sourced from PubChem (CID 163803537), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).